LSTA Q4 2017 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2,000-100.0% YoY

Gross Profit

$1,00050.0% margin

Operating Income

-$7M-366000.0% margin

Net Income

-$3M-143150.0% margin

EPS (Diluted)

$-4.79

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$81,490

Balance Sheet

Total Assets

$63M

Total Liabilities

$13M

Stockholders' Equity

$51M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2,000	$10M	-100.0%
Gross Profit	$1,000	$931,281	-99.9%
Operating Income	-$7M	-$6M	-23.7%
Net Income	-$3M	-$6M	+51.9%